Literature DB >> 31626292

Maternal cardiovascular complications at the time of delivery and subsequent re-hospitalization in the USA, 2010-16.

Noopur Goyal1, Jennifer S Herrick2, Shannon Son3, Torri D Metz3, Rashmee U Shah4.   

Abstract

AIMS: Cardiovascular (CV) complications are the leading cause of maternal morbidity and mortality. The objective was to estimate trends in the incidence of peripartum CV complications in the USA between 2010 and 2016. METHODS AND
RESULTS: This was a retrospective analyses using data from the Healthcare Cost and Utilization Project. We included women with delivery codes consistent with delivery, weighted to a national estimate. The primary outcome was the age-adjusted incidence of CV complications among all deliveries, including complications that occurred during re-hospitalizations. Complications were identified using International Classification of Diseases (ICD) codes. Joinpoint regression was used to evaluate time trends and complications were stratified by type. The secondary outcome was in-hospital maternal death among women with a CV complication. We identified a weighted estimate of 27 408 652 women hospitalized for delivery from 2010 to 2016. Including all years, the complication incidence was 7.36/1000 births [95% confidence interval (CI) 7.18-7.54], with an estimated annual percentage change of 5.8% (95% CI 3.7-7.8%). Cardiac dysrhythmia was the most common complication [3.98/1000 births (95% CI 3.88-4.08)] and acute myocardial infarction was the least common complication [0.11/1000 births (95% CI 0.10-0.11)]. The incidence of hypertension, acute myocardial infarction, and cardiac arrest increased over time, the incidence of congestive heart failure and acute cerebrovascular disease remained stable, the incidence of pulmonary heart disease increased from 2015 onward, and the incidence of cardiac dysrhythmia decreased in 2016. Complications during re-hospitalization accounted for 13.6% (95% CI 13.2-14.1%) of all complications and was highest for acute myocardial infarction [28.1% (95% CI 23.2-33.1)]. Among women with any complication, the mortality rate was 1.20 (95% CI 1.11-1.29) per 100 complications.
CONCLUSION: Our analyses suggest the rate of peripartum CV complications are increasing in the USA, which highlights the need for active efforts in research and prevention. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiovascular complications; Maternal morbidity; Maternal mortality; Pregnancy

Mesh:

Year:  2021        PMID: 31626292      PMCID: PMC8092990          DOI: 10.1093/ehjqcco/qcz056

Source DB:  PubMed          Journal:  Eur Heart J Qual Care Clin Outcomes        ISSN: 2058-1742


  24 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

2.  Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010.

Authors:  Aakriti Gupta; Yongfei Wang; John A Spertus; Mary Geda; Nancy Lorenze; Chileshe Nkonde-Price; Gail D'Onofrio; Judith H Lichtman; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2014-07-29       Impact factor: 24.094

3.  Addressing Maternal Mortality And Morbidity In California Through Public-Private Partnerships.

Authors:  Elliott K Main; Cathie Markow; Jeff Gould
Journal:  Health Aff (Millwood)       Date:  2018-09       Impact factor: 6.301

4.  Pregnancy-related mortality in the United States, 2006-2010.

Authors:  Andreea A Creanga; Cynthia J Berg; Carla Syverson; Kristi Seed; F Carol Bruce; William M Callaghan
Journal:  Obstet Gynecol       Date:  2015-01       Impact factor: 7.661

5.  Pregnancy-related cardiovascular deaths in California: beyond peripartum cardiomyopathy.

Authors:  Afshan B Hameed; Elizabeth S Lawton; Christy L McCain; Christine H Morton; Connie Mitchell; Elliott K Main; Elyse Foster
Journal:  Am J Obstet Gynecol       Date:  2015-05-13       Impact factor: 8.661

6.  ACOG Practice Bulletin No. 212: Pregnancy and Heart Disease.

Authors: 
Journal:  Obstet Gynecol       Date:  2019-05       Impact factor: 7.661

7.  Changes in the Prevalence of Chronic Hypertension in Pregnancy, United States, 1970 to 2010.

Authors:  Cande V Ananth; Christina M Duzyj; Stacy Yadava; Marlene Schwebel; Alan T N Tita; K S Joseph
Journal:  Hypertension       Date:  2019-09-09       Impact factor: 10.190

8.  Vital Signs: Pregnancy-Related Deaths, United States, 2011-2015, and Strategies for Prevention, 13 States, 2013-2017.

Authors:  Emily E Petersen; Nicole L Davis; David Goodman; Shanna Cox; Nikki Mayes; Emily Johnston; Carla Syverson; Kristi Seed; Carrie K Shapiro-Mendoza; William M Callaghan; Wanda Barfield
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-05-10       Impact factor: 17.586

9.  Spectrum of cardiac disease in maternity in a low-resource cohort in South Africa.

Authors:  Karen Sliwa; Elena Libhaber; Catherine Elliott; Zoe Momberg; Ayesha Osman; Liesl Zühlke; Tony Lachmann; Lauren Nicholson; Friedrich Thienemann; Jolien Roos-Hesselink; John Anthony
Journal:  Heart       Date:  2014-09-16       Impact factor: 5.994

10.  Cardiovascular disease in pregnancy: the South African perspective.

Authors:  John Anthony; Andrew Sarkin; Karen Sliwa
Journal:  Cardiovasc J Afr       Date:  2016 Mar-Apr       Impact factor: 1.167

View more
  1 in total

Review 1.  Management of Women With Acquired Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 3/5.

Authors:  Ki Park; C Noel Bairey Merz; Natalie A Bello; Melinda Davis; Claire Duvernoy; Islam Y Elgendy; Keith C Ferdinand; Afshan Hameed; Dipti Itchhaporia; Margo B Minissian; Harmony Reynolds; Puja Mehta; Andrea M Russo; Rashmee U Shah; Annabelle Santos Volgman; Janet Wei; Nanette K Wenger; Carl J Pepine; Kathryn J Lindley
Journal:  J Am Coll Cardiol       Date:  2021-04-13       Impact factor: 24.094

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.